세계의 화상 젤 및 화상 드레싱 시장 : 제품 유형별, 유형별, 원인별, 유통 경로별, 지역별(-2035년)

Global Burn Gel and Burn Dressing Market Research Report Information by Product Type [Gel (Hydrogel Burn Gels, Antibacterial Burn Gels, Lidocaine-based Burn Gels, Aloe Vera Burn Gels, Collagen-based Burn Gels, Others), Dressing (Alginate Dressings, Collagen Dressings, Hydrogel Dressings, Hydrocolloid Dressings, Wound Contact Layers, Film Dressings, Foam Dressings, Others)], by Type (Minor Burns, Partial Thickness Burns, Full Thickness Bums), by Cause (Thermal Burns, Electric Bums, Chemical Burns, Friction Burns), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035

Industry Overview

The global burn gel and burn dressing market is expected to achieve a value of USD 5,050.68 million by 2035, growing steadily at a CAGR of 8.06% during 2025-2035. Burn gel is a specialized topical solution that rapidly cools burns, alleviates pain, and reduces the risk of blistering or further tissue harm. Burn dressings, often pre-soaked with burn gel, act as a sterile barrier that shields the wound from contaminants while maintaining a moist healing environment. This combination ensures both instant relief and effective wound management.

The global burn gel and burn dressing market is seeing huge benefits from the rapid technological changes, which are changing the way wound management is done by patients themselves. The market of burn care is basically changing with silver- and honey-infused antimicrobial dressings, collagen-based bioactive solutions, and hydrogel dressings, which reduce recovery time by as much as 50%. Some of the fresh concepts, like smart and real-time monitoring, nanotechnology-based gels, and 3D printing skins, are quickly bringing in a recovery process that is not only faster and more cost-efficient but is also cutting down on hospitalization expenses by 20-25% while delivering superior clinical outcomes for burn patients.

Major Company Development

Safaeguard Medical has undergone a major development, turning it more to the advanced emergency care technologies, thus highlighting its mission to save lives in critical situations. It has brought in new technologies in burn treatment, management of the airway, and hemorrhage control as well as training modules for professionals in the healthcare and defense industries. Through this dual approach of innovation and education, emergency responders receive not only the right equipment but also the necessary skills. Safeguard Medical's commitment to excellence and accessibility continues to set new benchmarks in the industry, reinforcing its leadership role in shaping global emergency care while consistently improving patient outcomes worldwide.

Key Players

Key competitors in the global burn gel and burn dressing market are Cardinal Health, Smith + Nephew, Integra Lifesciences Holdings Corporation, 3M, ConvaTech Group Plc, Paul Hartmann AG, Coloplast, Burnshield, Safeguard Medical, and DeRoyal Industries, Inc.

Report Attribute Details

Market Size 2024 USD 2,148.83 Million

Market Size 2035 USD 5,050.68 Million

CAGR (2025-2035) 8.06%

Base Year 2024

Market Forecast Period 2025-2035

Industry Segmentations

By Product Type: Gel - 9.44%, Dressing - 7.59%.

By Type: Minor Burns - 6.61%, Partial Thickness Burns - 7.80%.

By Cause: Thermal Burns - 8.04%, Electrical Burns - 10.25%.

By Distribution Channel: Hospital pharmacies - 8.40%, Retail Pharmacies - 7.05%.

Regional Analysis

The North American market is a recipient of technological leadership, having advanced burn dressings available almost everywhere, and a strong government support for healthcare research as its main advantages. The region has a high incidence of burn injuries treated with hydrogel and silver-infused dressings. With the U.S. and Canada generating USD 732.68 million and USD 161.98 million respectively, North America maintains a dominant regional share in 2024.

Europe continues to hold a significant market share due to established healthcare systems and higher patient awareness levels. Policies aimed at lowering the costs of hospitalization are acting as a stimulus to the acceptance of cost-effective burn management solutions by the users. Germany, the UK, and France collectively drive Europe's market, with values of USD 165.85 million, USD 126.88 million, and USD 103.41 million.

The growth of the Asia-Pacific region is on an uptrend and the reasons are a number of urban fire accidents, the medical sector reform, and the rising number of workplace hazards in the region. While Japan and South Korea are devoting their money to luxury wound care products, India and Southeast Asia are concentrating on making burn dressings more affordable. China (USD 109.52 million), Japan (USD 91.91 million), and India (USD 79.25 million) highlight Asia-Pacific's emerging growth potential.

In Latin America and MEA, the market is gradually expanding as healthcare facilities adopt advanced wound care solutions. The emphasis is on reducing infection risks through silver-based burn dressings. Government health initiatives and NGO support are helping raise awareness about burn management practices in underserved communities.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TYPE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 INCREASING INCIDENCE OF BURNS
  • 4.2.2 ADVANCEMENTS IN WOUND CARE TECHNOLOGY
  • 4.2.3 INCREASING SURGICAL PROCEDURES
• 4.3 RESTRAINTS
  • 4.3.1 LACK OF AWARENESS IN DEVELOPING REGIONS
  • 4.3.2 STRINGENT REGULATORY APPROVALS
• 4.4 OPPORTUNITY
  • 4.4.1 RISING AGING POPULATION
  • 4.4.2 RISING DEMAND FOR ANTIMICROBIAL DRESSINGS
  • 4.4.3 EXPANSION OF E-COMMERCE PLATFORMS

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 THREAT OF SUBSTITUTES
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF RIVALRY
• 5.2 IMPACT OF COVID-19 ON THE GLOBAL BURN GEL AND BURN DRESSING MARKET

6 GLOBAL BURN GEL AND BURN DRESSING MARKET, BY PRODUCT TYPE

• 6.1 OVERVIEW
• 6.2 GEL
  • 6.2.1 HYDROGEL BURN GELS
  • 6.2.2 ANTIBACTERIAL BURN GELS
  • 6.2.3 LIDOCAINE-BASED BURN GELS
  • 6.2.4 ALOE VERA BURN GELS
  • 6.2.5 COLLAGEN-BASED BURN GELS
  • 6.2.6 OTHERS
• 6.3 DRESSING
  • 6.3.1 ALGINATE DRESSINGS
  • 6.3.2 COLLAGEN DRESSINGS
  • 6.3.3 HYDROGEL DRESSINGS
  • 6.3.4 HYDROCOLLOID DRESSINGS
  • 6.3.5 WOUND CONTACT LAYERS
  • 6.3.6 FILM DRESSINGS
  • 6.3.7 FOAM DRESSINGS
  • 6.3.8 OTHERS

7 GLOBAL BURN GEL AND BURN DRESSING MARKET, BY TYPE

• 7.1 OVERVIEW
• 7.2 MINOR BURNS
• 7.3 PARTIAL THICKNESS BURNS
• 7.4 FULL THICKNESS BURNS

8 GLOBAL BURN GEL AND BURN DRESSING MARKET, BY CAUSE

• 8.1 OVERVIEW
• 8.2 THERMAL BURNS
• 8.3 ELECTRICAL BURNS
• 8.4 RADIATION BURNS
• 8.5 CHEMICAL BURNS
• 8.6 FRICTION BURNS

9 GLOBAL BURN GEL AND BURN DRESSING MARKET, BY DISTRIBUTION CHANNEL

• 9.1 OVERVIEW
• 9.2 HOSPITAL PHARMACIES
• 9.3 RETAIL PHARMACIES
• 9.4 ONLINE PHARMACIES

10 GLOBAL BURN GEL AND BURN DRESSING MARKET, BY REGION

• 10.1 OVERVIEW
• 10.2 NORTH AMERICA
  • 10.2.1 US
  • 10.2.2 CANADA
• 10.3 EUROPE
  • 10.3.1 GERMANY
  • 10.3.2 FRANCE
  • 10.3.3 UK
  • 10.3.4 ITALY
  • 10.3.5 SPAIN
  • 10.3.6 REST OF EUROPE
• 10.4 ASIA-PACIFIC
  • 10.4.1 CHINA
  • 10.4.2 INDIA
  • 10.4.3 JAPAN
  • 10.4.4 AUSTRALIA
  • 10.4.5 SOUTH KOREA
  • 10.4.6 REST OF ASIA-PACIFIC
• 10.5 REST OF THE WORLD
  • 10.5.1 MIDDLE EAST AND AFRICA
  • 10.5.2 SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 MARKET SHARE ANALYSIS, 2024
• 11.3 COMPETITOR DASHBOARD
• 11.4 PUBLIC PLAYERS STOCK SUMMARY
• 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL

12 COMPANY PROFILES

• 12.1 CARDINAL HEALTH
  • 12.1.1 COMPANY OVERVIEW
  • 12.1.2 FINANCIAL OVERVIEW
  • 12.1.3 PRODUCTS OFFERED
  • 12.1.4 KEY DEVELOPMENTS
  • 12.1.5 SWOT ANALYSIS
  • 12.1.6 KEY STRATEGIES
• 12.2 SMITH+NEPHEW
  • 12.2.1 COMPANY OVERVIEW
  • 12.2.2 FINANCIAL OVERVIEW
  • 12.2.3 PRODUCTS OFFERED
  • 12.2.4 KEY DEVELOPMENTS
  • 12.2.5 SWOT ANALYSIS
  • 12.2.6 KEY STRATEGIES
• 12.3 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 12.3.1 COMPANY OVERVIEW
  • 12.3.2 FINANCIAL OVERVIEW
  • 12.3.3 PRODUCTS OFFERED
  • 12.3.4 KEY DEVELOPMENTS
  • 12.3.5 SWOT ANALYSIS
  • 12.3.6 KEY STRATEGIES
• 12.4 3M
  • 12.4.1 COMPANY OVERVIEW
  • 12.4.2 FINANCIAL OVERVIEW
  • 12.4.3 PRODUCTS OFFERED
  • 12.4.4 KEY DEVELOPMENTS
  • 12.4.5 KEY STRATEGIES
• 12.5 CONVATEC GROUP PLC
  • 12.5.1 COMPANY OVERVIEW
  • 12.5.2 FINANCIAL OVERVIEW
  • 12.5.3 PRODUCTS OFFERED
  • 12.5.4 KEY DEVELOPMENTS
  • 12.5.5 KEY STRATEGIES
• 12.6 BURNSHIELD
  • 12.6.1 COMPANY OVERVIEW
  • 12.6.2 FINANCIAL OVERVIEW
  • 12.6.3 PRODUCTS OFFERED
  • 12.6.4 KEY DEVELOPMENTS
  • 12.6.5 KEY STRATEGIES
• 12.7 SAFEGUARD MEDICAL
  • 12.7.1 COMPANY OVERVIEW
  • 12.7.2 FINANCIAL OVERVIEW
  • 12.7.3 PRODUCTS OFFERED
  • 12.7.4 KEY DEVELOPMENTS
  • 12.7.5 SWOT ANALYSIS
  • 12.7.6 KEY STRATEGIES
• 12.8 DEROYAL INDUSTRIES, INC
  • 12.8.1 COMPANY OVERVIEW
  • 12.8.2 FINANCIAL OVERVIEW
  • 12.8.3 PRODUCT OFFERED
  • 12.8.4 KEY DEVELOPMENTS
  • 12.8.5 KEY STRATEGIES
• 12.9 COLOPLAST
  • 12.9.1 COMPANY OVERVIEW
  • 12.9.2 FINANCIAL OVERVIEW
  • 12.9.3 PRODUCTS OFFERED
  • 12.9.4 KEY DEVELOPMENTS
  • 12.9.5 KEY STRATEGIES
• 12.10 PAUL HARTMANN AG
  • 12.10.1 COMPANY OVERVIEW
  • 12.10.2 FINANCIAL OVERVIEW
  • 12.10.3 PRODUCTS OFFERED
  • 12.10.4 KEY DEVELOPMENTS
  • 12.10.5 SWOT ANALYSIS
  • 12.10.6 KEY STRATEGIES

13 DATA CITATIONS